281 related articles for article (PubMed ID: 22992387)
1. NOTCH1 inhibition in vivo results in mammary tumor regression and reduced mammary tumorsphere-forming activity in vitro.
Simmons MJ; Serra R; Hermance N; Kelliher MA
Breast Cancer Res; 2012 Sep; 14(5):R126. PubMed ID: 22992387
[TBL] [Abstract][Full Text] [Related]
2. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
[TBL] [Abstract][Full Text] [Related]
3. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways.
Iwanaga R; Wang CA; Micalizzi DS; Harrell JC; Jedlicka P; Sartorius CA; Kabos P; Farabaugh SM; Bradford AP; Ford HL
Breast Cancer Res; 2012 Jul; 14(4):R100. PubMed ID: 22765220
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer.
Schwab LP; Peacock DL; Majumdar D; Ingels JF; Jensen LC; Smith KD; Cushing RC; Seagroves TN
Breast Cancer Res; 2012 Jan; 14(1):R6. PubMed ID: 22225988
[TBL] [Abstract][Full Text] [Related]
5. Mammary stem cells and breast cancer--role of Notch signalling.
Farnie G; Clarke RB
Stem Cell Rev; 2007 Jun; 3(2):169-75. PubMed ID: 17873349
[TBL] [Abstract][Full Text] [Related]
6. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
[TBL] [Abstract][Full Text] [Related]
7. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.
Won HY; Lee JY; Shin DH; Park JH; Nam JS; Kim HC; Kong G
FASEB J; 2012 Dec; 26(12):5002-13. PubMed ID: 22954590
[TBL] [Abstract][Full Text] [Related]
8. Notch activation stimulates migration of breast cancer cells and promotes tumor growth.
Bolós V; Mira E; Martínez-Poveda B; Luxán G; Cañamero M; Martínez-A C; Mañes S; de la Pompa JL
Breast Cancer Res; 2013; 15(4):R54. PubMed ID: 23826634
[TBL] [Abstract][Full Text] [Related]
9. Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity.
Sriram R; Lo V; Pryce B; Antonova L; Mears AJ; Daneshmand M; McKay B; Conway SJ; Muller WJ; Sabourin LA
Breast Cancer Res; 2015 Jan; 17(1):7. PubMed ID: 25592291
[TBL] [Abstract][Full Text] [Related]
10. Interplay between CCR7 and Notch1 axes promotes stemness in MMTV-PyMT mammary cancer cells.
Boyle ST; Gieniec KA; Gregor CE; Faulkner JW; McColl SR; Kochetkova M
Mol Cancer; 2017 Jan; 16(1):19. PubMed ID: 28137279
[TBL] [Abstract][Full Text] [Related]
11. Intracellular Notch1 Signaling in Cancer-Associated Fibroblasts Dictates the Plasticity and Stemness of Melanoma Stem/Initiating Cells.
Du Y; Shao H; Moller M; Prokupets R; Tse YT; Liu ZJ
Stem Cells; 2019 Jul; 37(7):865-875. PubMed ID: 30941836
[TBL] [Abstract][Full Text] [Related]
12. Notch pathway activation is essential for maintenance of stem-like cells in early tongue cancer.
Upadhyay P; Nair S; Kaur E; Aich J; Dani P; Sethunath V; Gardi N; Chandrani P; Godbole M; Sonawane K; Prasad R; Kannan S; Agarwal B; Kane S; Gupta S; Dutt S; Dutt A
Oncotarget; 2016 Aug; 7(31):50437-50449. PubMed ID: 27391340
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors.
Hu C; Diévart A; Lupien M; Calvo E; Tremblay G; Jolicoeur P
Am J Pathol; 2006 Mar; 168(3):973-90. PubMed ID: 16507912
[TBL] [Abstract][Full Text] [Related]
14. Coordinate hyperactivation of Notch1 and Ras/MAPK pathways correlates with poor patient survival: novel therapeutic strategy for aggressive breast cancers.
Mittal S; Sharma A; Balaji SA; Gowda MC; Dighe RR; Kumar RV; Rangarajan A
Mol Cancer Ther; 2014 Dec; 13(12):3198-3209. PubMed ID: 25253780
[TBL] [Abstract][Full Text] [Related]
15. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.
Tatarek J; Cullion K; Ashworth T; Gerstein R; Aster JC; Kelliher MA
Blood; 2011 Aug; 118(6):1579-90. PubMed ID: 21670468
[TBL] [Abstract][Full Text] [Related]
16. Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor.
Beltran AS; Rivenbark AG; Richardson BT; Yuan X; Quian H; Hunt JP; Zimmerman E; Graves LM; Blancafort P
Breast Cancer Res; 2011 Sep; 13(5):R94. PubMed ID: 21952072
[TBL] [Abstract][Full Text] [Related]
17. Characterization of in vivo chemoresistant human hepatocellular carcinoma cells with transendothelial differentiation capacities.
Marfels C; Hoehn M; Wagner E; Günther M
BMC Cancer; 2013 Apr; 13():176. PubMed ID: 23547746
[TBL] [Abstract][Full Text] [Related]
18. Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo.
Yu XM; Phan T; Patel PN; Jaskula-Sztul R; Chen H
Cancer; 2013 Feb; 119(4):774-81. PubMed ID: 22991264
[TBL] [Abstract][Full Text] [Related]
19. CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.
Lo PK; Kanojia D; Liu X; Singh UP; Berger FG; Wang Q; Chen H
Oncogene; 2012 May; 31(21):2614-26. PubMed ID: 21996747
[TBL] [Abstract][Full Text] [Related]
20. c-Jun N-terminal kinase 2 prevents luminal cell commitment in normal mammary glands and tumors by inhibiting p53/Notch1 and breast cancer gene 1 expression.
Cantrell MA; Ebelt ND; Pfefferle AD; Perou CM; Van Den Berg CL
Oncotarget; 2015 May; 6(14):11863-81. PubMed ID: 25970777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
